Harvard Bioscience Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 7, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	30	299	930	2,322	1,140	2,901
Market Cap Growth	38.44%	-67.84%	-59.94%	103.71%	-60.71%	71.57%
Enterprise Value	66.93	333.23	969.2	2,359	1,189	2,950
Last Close Price	6.63	6.69	21.10	53.50	27.70	70.50
Forward PE	-	7.87	17.58	23.26	17.87	22.03
PEG Ratio	-	1.03	1.03	1.03	1.03	1.03
PS Ratio	0.35	3.46	9.88	20.68	10.06	24.39
PB Ratio	2.98	21.78	14.68	31.77	15.78	34.78
P/FCF Ratio	15.66	54.67	-	189.68	-	43292.10
P/OCF Ratio	9.71	44.45	645.81	165.50	989.28	2298.39
EV/Sales Ratio	0.78	3.85	10.30	21.01	10.49	24.81
EV/EBITDA Ratio	8.56	-	1024.52	265.26	1852.63	304.50
EV/EBIT Ratio	30.66	-	-	1245.36	-	1427.74
EV/FCF Ratio	35.04	60.91	-	192.71	-	44025.50
Debt / Equity Ratio	4.24	3.11	0.10	0.49	0.67	0.62
Debt / EBITDA Ratio	7.67	-	45.81	4.65	84.49	5.88
Debt / FCF Ratio	22.29	7.81	-	3.38	-	850.15
Net Debt / Equity Ratio	3.53	2.49	0.62	0.51	0.69	0.59
Net Debt / EBITDA Ratio	6.39	-0.80	41.47	4.17	77.47	5.07
Net Debt / FCF Ratio	18.57	6.24	-32.58	3.03	-113.55	733.42
Asset Turnover	1.08	0.84	0.71	0.79	0.74	0.75
Inventory Turnover	1.65	1.66	1.64	1.81	1.94	2.06
Quick Ratio	0.91	1.12	0.35	0.77	0.91	1.17
Current Ratio	1.99	2.20	0.82	1.85	2.20	2.43
Return on Equity (ROE)	-139.92%	-169.98%	-26.18%	-10.83%	-15.12%	-3.12%
Return on Assets (ROA)	-0.11%	-46.51%	-4.91%	1.50%	-4.64%	1.38%
Return on Invested Capital (ROIC)	-0.18%	-63.91%	-6.09%	1.83%	-5.61%	1.70%
Return on Capital Employed (ROCE)	-0.15%	-74.86%	-6.81%	1.63%	-5.35%	1.52%
FCF Yield	6.39%	1.83%	-	0.53%	-	0.00%
Buyback Yield / Dilution	-1.91%	-1.96%	-2.64%	-2.43%	-2.65%	-4.41%
Total Shareholder Return	-1.91%	-1.96%	-2.64%	-2.43%	-2.65%	-4.41%

SEC Filings: 10-K · 10-Q